Philip Toleikis
Corporate Officer/Principal chez Medway Working Group
Fortune : 2 M $ au 30/04/2024
Postes actifs de Philip Toleikis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - | - |
Historique de carrière de Philip Toleikis
Anciens postes connus de Philip Toleikis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SERNOVA CORP. | Directeur/Membre du Conseil | 19/10/2010 | 30/04/2024 |
| Directeur Général | 28/04/2009 | 05/09/2023 | |
| Directeur Technique/Scientifique/R&D | 05/09/2023 | 30/04/2024 | |
| Investor Relations Contact | - | 28/07/2014 | |
| Public Communications Contact | 19/10/2010 | 28/07/2014 | |
| President | 28/04/2009 | 05/09/2023 | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2006 | 01/01/2006 |
Formation de Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Statistiques
Internationale
| Canada | 5 |
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Bourse
- Insiders
- Philip Toleikis
- Expérience
